On the possibility of "progress" in managing biomedical technologies: markets, lotteries, and rational moral standards in organ transplantation.
Shapiro
Michael H
MH
University of Southern California, USA.
D016223:Advance Directives / Q000191:economics / Q000941:ethics; D020811:Biomedical Technology; D002102:Cadaver; D003132:Commerce; D032921:Consensus; D003657:Decision Making / Q000941:ethics*; D026689:Ethical Analysis; D028663:Ethical Theory; D017041:Ethics Committees; D006292:Health Priorities; D006801:Humans; D009014:Morals; D016377:Organ Transplantation / Q000941:ethics*; D018579:Patient Selection / Q000941:ethics*; D026684:Personal Autonomy; D019724:Presumed Consent; D011897:Random Allocation; D040841:Resource Allocation / Q000941:ethics*; D012928:Social Desirability; D012935:Social Justice; D012945:Social Values; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting / Q000191:economics / Q000941:ethics; D009927:Tissue and Organ Procurement / Q000941:ethics*; D035501:Uncertainty; D014850:Waiting Lists